BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 32456125)

  • 1. Molecular Biology of
    Menge C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of
    Menge C
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32967277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
    Detzner J; Pohlentz G; Müthing J
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
    Liu Y; Tian S; Thaker H; Dong M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Shiga/Vero toxins in pathogenesis.
    Obata F; Obrig T
    Microbiol Spectr; 2014 Jun; 2(3):. PubMed ID: 25530918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4.
    Tran SL; Billoud L; Lewis SB; Phillips AD; Schüller S
    Cell Microbiol; 2014 Aug; 16(8):1255-66. PubMed ID: 24612002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells.
    Lee KS; Park JY; Jeong YJ; Lee MS
    J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Shiga-toxin producing escherichia coli.
    Melton-Celsa A; Mohawk K; Teel L; O'Brien A
    Curr Top Microbiol Immunol; 2012; 357():67-103. PubMed ID: 21915773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxins and stx phages: highly diverse entities.
    Krüger A; Lucchesi PM
    Microbiology (Reading); 2015 Mar; 161(Pt 3):451-62. PubMed ID: 25479836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue Responses to Shiga Toxin in Human Intestinal Organoids.
    Pradhan S; Karve SS; Weiss AA; Hawkins J; Poling HM; Helmrath MA; Wells JM; McCauley HA
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):171-190. PubMed ID: 32145469
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lee KS; Jeong YJ; Lee MS
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34208170
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated in Poland.
    Januszkiewicz A; Rastawicki W
    Pol J Microbiol; 2016 Aug; 65(3):261-269. PubMed ID: 29334059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli O104:H4 Pathogenesis: an Enteroaggregative E. coli/Shiga Toxin-Producing E. coli Explosive Cocktail of High Virulence.
    Navarro-Garcia F
    Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence profiling and disease association of verocytotoxin-producing Escherichia coli O157 and non-O157 isolates in Belgium.
    Buvens G; Piérard D
    Foodborne Pathog Dis; 2012 Jun; 9(6):530-5. PubMed ID: 22545959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli.
    Melton-Celsa AR; O'Brien AD
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing
    Lee Y; Kim MH; Alves DR; Kim S; Lee LP; Sung JH; Park S
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.